10th-Feb-2012 09:50
Source: BSE
GlaxoSmithKline- FY11 results on Feb 16, 2012
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 16, 2012, inter alia, to consider approval of audited financial re...
8th-Nov-2011 10:54
Source: NSE
GlaxoSmithKline Pharmaceuticals Limited
Glaxosmithkline Pharmaceuticals Limited has informed the Exchange that the Board of Directors at its Meeting held on November 04, 2011, have appointed Mr. A.N. Roy as Additional Non-Executive Independ...
7th-Nov-2011 15:45
Source: BSE
GlaxoSmithKline- Change in Directorate
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that the Board of Directors at its Meeting held on November 04, 2011, have appointed Mr. A. N. Roy as Additional Non-Executive Independent Director...
4th-Nov-2011 16:28
Source: BSE
GlaxoSmithKline- Announces Q3 results
GlaxoSmithKline Pharmaceuticals Ltd has announced the following results for the quarter ended September 30, 2011:
The Unaudited results for the Quarter ended September 30, 2011
The Compa...
19th-Oct-2011 15:40
Source: BSE
GlaxoSmithKline- Q3 results on Nov 04, 2011
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 04, 2011, inter alia, to consider approval of unaudited financial ...
12th-Aug-2011 16:51
Source: BSE
GlaxoSmithKline- Change in Directorate
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE about the following changes in the Directorate with effect from August 01, 2011.
1. Mr. Raju Krishnaswamy has been appointed as an Executive...
11th-Aug-2011 09:58
Source: NSE
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2011 as follows: Net Sales of Rs. 56154 lacs for quarter ending on 30...
11th-Aug-2011 09:49
Source: NSE
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has submitted to the Exchange the Standalone Financial Results for the period ended June 30,2011.